Abstract
Vulvar carcinoma is a relatively rare malignancy and there is a paucity of data, especially from India and other developing countries regarding the prognostic factors impacting recurrence and survival. A retrospective observational study was conducted in the Department of Gynecologic Oncology at a tertiary care, regional cancer institute, including all patients with carcinoma vulva who underwent surgery between 2009 and 2018. Demographic profile, surgical-pathological information, details of neo-adjuvant chemotherapy, adjuvant radiation and chemotherapy, and peri-operative complications were analyzed. Long-term follow-up data was gathered, with an evaluation of various prognostic factors impacting recurrence and overall survival outcome. Forty-five cases with mean age of 56.2 years (range 29–82) were treated during the study period. Surgery was the initial treatment modality in 41 (91.1%) cases. Neo-adjuvant chemotherapy prior to surgery was given to four cases. After complete surgico-pathological staging, most patients had stage I disease (26 cases, 57.8%) and 22.2% had stage II disease. Owing to microscopic lymph node involvement, seven cases (15.6%) belonged to FIGO stage III disease. Two cases had stage IVA disease with fixed groin nodes. Adjuvant chemotherapy in the form of 5-fluoro uracil and cisplatin was administered to four out of the nine patients with nodal involvement. The remaining five were advised adjuvant groin radiation. At a median follow-up of 34 months (range 2–114 months), 12 cases (26.7%) experienced a recurrence and one case with stage IVA disease progressed during adjuvant chemotherapy. The 5-year overall survival was 76.6% and the 5-year disease-free survival was 69.6%. There were a total number of 10 deaths, of which seven were due to disease recurrence or progression and the remaining 30% of deaths were due to medical co-morbid conditions. Overall survival was negatively impacted by increasing age (age > 60 years), number of positive nodes, presence of perinodal spread, and stage of the disease. Recurrence-free survival was significantly reduced in those with the presence of peri-nodal spread and lympho-vascular space invasion. The incidence of lymph node metastasis was found to be higher in patients with age > 60 years, increasing tumor size, presence of lympho-vascular space invasion and the number of lymph nodes removed. In carcinoma vulva, treatment should be individualized with multidisciplinary cooperation. In our series, we found that the stage of disease, nodal positivity, and nodal positivity with extra-capsular spread were significant prognostic factors impacting survival on analysis. Lymph nodal positivity was associated with increasing tumour size, presence of lympho-vascular invasion, and patient age.
Similar content being viewed by others
References
Judson PL, Habermann EB, Baxter NN et al (2006) Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 107:1018–1022. https://doi.org/10.1097/01.AOG.0000210268.57527.a1
Hacker NF (2000) Vulvar cancer. In: Berek JS, Hacker NF (eds) Practical Gynecologic Oncology, 3rd edn. Williams and Wilkins, Baltimore, MD, pp 553–596
Xanthopoulos EP, Grover S, Puri PM et al (2018) Survival benefit of adjuvant radiation Therapy in Node-positive Vulvar Cancer. Am J Clin Oncol 41:845–850. https://doi.org/10.1097/COC.0000000000000393
Homesley HD, Bundy BN, Sedlis A, Adcock L (1986) Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 68:733–740
Pecorino B, Scibilia G, Ferrara M et al (2020) Prognostic factors and surgical treatment in vulvar carcinoma: Single center experience. J Obstet Gynaecol Res 46:1871–1878. https://doi.org/10.1111/jog.14368
Karataşlı V, Erkılınç S, Çakır İ et al (2020) The effect of lymph node metastasis on overall survival and disease-free survival in vulvar cancer patients. Ginekol Pol 91:62–67. https://doi.org/10.5603/GP.2020.0018
Woelber L, Mahner S, Voelker K et al (2009) Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Res 29:545–552
Te Grootenhuis NC, van der Zee AGJ, van Doorn HC et al (2016) Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol 140:8–14. https://doi.org/10.1016/j.ygyno.2015.09.077
Sznurkowski JJ, Emerich J (2010) Characteristic features of recurrences of squamous cell carcinoma of the vulva. Ginekol Pol 81:12–19
Gadducci A, Ferrero A, Tana R et al (2012) Prognostic value of lymph node status and number of removed nodes in patients with squamous cell carcinoma of the vulva treated with modified radical vulvectomy and inguinal-femoral lymphadenectomy. Eur J Gynaecol Oncol 33:640–643
Te Grootenhuis NC, Pouwer A-FW, de Bock GH et al (2018) Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review. Gynecol Oncol 148:622–631. https://doi.org/10.1016/j.ygyno.2017.11.006
Woelber L, Griebel L-F, Eulenburg C et al (1990) (2016) Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study. Eur J Cancer Oxf Engl 69:180–188. https://doi.org/10.1016/j.ejca.2016.09.038
Sznurkowski JJ, Milczek T, Emerich J (2013) Prognostic factors and a value of 2009 FIGO staging system in vulvar cancer. Arch Gynecol Obstet 287:1211–1218. https://doi.org/10.1007/s00404-012-2683-x
Klapdor R, Wölber L, Hanker L et al (2019) Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study. Gynecol Oncol 154:565–570. https://doi.org/10.1016/j.ygyno.2019.06.013
Martinez-Castro P, Poveda A, Guinot JL, Minig L (2016) Treatment of Inoperable Vulvar Cancer: Where We Come From and Where Are We Going. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc 26:1694–1698. https://doi.org/10.1097/IGC.0000000000000815
Meelapkij P, Suprasert P, Baisai O (2018) Treatment Outcomes of Patients with Squamous Cell Carcinoma of the Vulva: The Largest Series from a Tertiary Care Hospital. Obstet Gynecol Int 2018:4723167. https://doi.org/10.1155/2018/4723167
Bellati F, Angioli R, Manci N et al (2005) Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. Gynecol Oncol 96:227–231. https://doi.org/10.1016/j.ygyno.2004.09.016
Gill BS, Bernard ME, Lin JF et al (2015) Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis. Gynecol Oncol 137:365–372. https://doi.org/10.1016/j.ygyno.2015.03.056
Barlow EL, Kang Y-J, Hacker NF, Canfell K (2015) Changing Trends in Vulvar Cancer Incidence and Mortality Rates in Australia Since 1982. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc 25:1683–1689. https://doi.org/10.1097/IGC.0000000000000547
Kang Y-J, Smith M, Barlow E et al (2017) Vulvar cancer in high-income countries: Increasing burden of disease. Int J Cancer 141:2174–2186. https://doi.org/10.1002/ijc.30900
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Consent to Participate
Relatives of all patients have given their written informed consent.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kansal, Y., Kundargi, R.S., R, P.V. et al. Lymph Node Metastasis and Patterns of Recurrence in Vulvar Carcinoma: 10 Years’ Single Center Experience. Indian J Surg Oncol 14, 619–627 (2023). https://doi.org/10.1007/s13193-023-01704-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-023-01704-0